FDA
-
-
-
-
-
-
-
Awakn Life Sciences Receives UK State Funding to Identify Optimal Pathway to Market in UK & US for Its Lead Clinical Development Program - Ketamine-Assisted Therapy for Alcohol Use Disorder
-
324,774 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

